Author
Listed:
- Xiaoliang Ba
(University of Cambridge)
- Claire L. Raisen
(University of Cambridge)
- Olivier Restif
(University of Cambridge)
- Lina Maria Cavaco
(Statens Serum Institut)
- Carina Vingsbo Lundberg
(Statens Serum Institut)
- Jean Y. H. Lee
(The University of Melbourne at The Doherty Institute for Infection and Immunity)
- Benjamin P. Howden
(The University of Melbourne at The Doherty Institute for Infection and Immunity)
- Mette D. Bartels
(Copenhagen University Hospital - Amager and Hvidovre
University of Copenhagen)
- Birgit Strommenger
(Robert Koch Institute, Wernigerode Branch)
- Ewan M. Harrison
(University of Cambridge
University of Cambridge
Wellcome Sanger Institute)
- Anders Rhod Larsen
(Statens Serum Institut)
- Mark A. Holmes
(University of Cambridge)
- Jesper Larsen
(Statens Serum Institut)
Abstract
Global spread of multidrug-resistant, hospital-adapted Staphylococcus epidermidis lineages underscores the need for new therapeutic strategies. Here we show that many S. epidermidis isolates belonging to these lineages display cryptic susceptibility to penicillin/β-lactamase inhibitor combinations under in vitro conditions, despite carrying the methicillin resistance gene mecA. Using a mouse thigh model of S. epidermidis infection, we demonstrate that single-dose treatment with amoxicillin/clavulanic acid significantly reduces methicillin-resistant S. epidermidis loads without leading to detectable resistance development. On the other hand, we also show that methicillin-resistant S. epidermidis is capable of developing increased resistance to amoxicillin/clavulanic acid during long-term in vitro exposure to these drugs. These findings suggest that penicillin/β-lactamase inhibitor combinations could be a promising therapeutic candidate for treatment of a high proportion of methicillin-resistant S. epidermidis infections, although the in vivo risk of resistance development needs to be further addressed before they can be incorporated into clinical trials.
Suggested Citation
Xiaoliang Ba & Claire L. Raisen & Olivier Restif & Lina Maria Cavaco & Carina Vingsbo Lundberg & Jean Y. H. Lee & Benjamin P. Howden & Mette D. Bartels & Birgit Strommenger & Ewan M. Harrison & Anders, 2023.
"Cryptic susceptibility to penicillin/β-lactamase inhibitor combinations in emerging multidrug-resistant, hospital-adapted Staphylococcus epidermidis lineages,"
Nature Communications, Nature, vol. 14(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-42245-y
DOI: 10.1038/s41467-023-42245-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-42245-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.